Stockscreener 앱 받기
2.30
1.29%
-0.03
전일 마감가:
$2.33
열려 있는:
$2.4
하루 거래량:
8,373
Relative Volume:
0.06
시가총액:
$6.12M
수익:
-
순이익/손실:
$-13.56M
주가수익비율:
-0.2364
EPS:
-9.7281
순현금흐름:
$-12.24M
1주 성능:
-27.22%
1개월 성능:
+9.52%
6개월 성능:
-52.33%
1년 성능:
-77.00%
1일 변동 폭
$2.30
$2.45
1주일 범위
$2.08
$3.17
52주 변동 폭
$1.76
$19.63
프로세사 파마슈티컬스 Stock (PCSA) Company Profile
명칭
Processa Pharmaceuticals Inc
전화
443-776-3133
주소
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
2.30 | 6.12M | 0 | -13.56M | -12.24M | -9.7281 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-25 | 개시 | H.C. Wainwright | Buy |
프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스
Trading Recap: Does Processa Pharmaceuticals Inc have a sustainable dividend2026 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn
Earnings Recap: Does Processa Pharmaceuticals Inc have strong fundamentalsRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in Processa Pharmaceuticals Inc (PCSA) - Stock Titan
Processa Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings - marketscreener.com
Aug Macro: Can Processa Pharmaceuticals Inc maintain sales growthMarket Growth Summary & Daily Price Action Insights - baoquankhu1.vn
Processa Pharmaceuticals Inc: Fundamental Analysis and Financial Ratings - marketscreener.com
Analyst Calls: What are the risks of holding Processa Pharmaceuticals Inc2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Processa Pharmaceuticals 2025 Annual Report: Next Generation Cancer Therapies, Regulatory Strategy, Pipeline, and Intellectual Property Overview - Minichart
Processa Pharmaceuticals 2025 10-K: $0 revenue, $(10.36) EPS on $(13.56)M net loss - TradingView
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[10-K] Processa Pharmaceuticals, I... - Stock Titan
Processa Pharmaceuticals Inc expected to post a loss of $1.50 a shareEarnings Preview - TradingView
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Gardner News
Growth Recap: Whats Processa Pharmaceuticals Incs historical return2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
EV Market: Can Processa Pharmaceuticals Inc maintain sales growthPortfolio Performance Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Aug Summary: Does Processa Pharmaceuticals Inc have a sustainable dividendWeekly Market Report & Entry Point Strategy Guides - baoquankhu1.vn
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Panama City News Herald
Can Processa Pharmaceuticals Inc maintain sales growthJuly 2025 Trends & Weekly Top Performers Watchlists - baoquankhu1.vn
Processa Pharmaceuticals Stock Quote, Share Price, News and Analysis - Longbridge
Aug Setups: Will Vishay Intertechnology Inc benefit from current market trends2025 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Death Cross: What is Processa Pharmaceuticals Incs valuation compared to sectorRate Hike & Weekly Top Performers Watchlists - baoquankhu1.vn
PCSA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PCSA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PCSA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Chiliz Group boosts Processa (PCSA) stake to 13% with added share buy - Stock Titan
Smart Money: Should I hold or sell Processa Pharmaceuticals Inc nowGlobal Markets & Daily Profit Focused Stock Screening - baoquankhu1.vn
Will Processa Pharmaceuticals Inc. benefit from green energy policiesJuly 2025 Gainers & Smart Swing Trading Alerts - mfd.ru
Processa Ends PCS12852 Licensing Pact With Intact Therapeutics - TipRanks
Processa Pharmaceuticals (PCSA) term sheet for PCS12852 expires without final license - Stock Titan
Will Processa Pharmaceuticals Inc. benefit from seasonalityJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - mfd.ru
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Breakout Move: What is Processa Pharmaceuticals Incs valuation compared to sectorQuarterly Market Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Will Processa Pharmaceuticals Inc. outperform small cap indexesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - mfd.ru
Does Processa Pharmaceuticals Inc. have strong fundamentalsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
What’s Processa Pharmaceuticals Inc.’s historical returnQuarterly Profit Review & Momentum Based Trading Ideas - mfd.ru
Institution Moves: Is Processa Pharmaceuticals Inc impacted by rising ratesEarnings Growth Summary & Consistent Profit Alerts - baoquankhu1.vn
Intracoastal Capital discloses 8.1% Processa (PCSA) ownership stake - Stock Titan
Aug Technicals: Does Processa Pharmaceuticals Inc have a sustainable dividendJuly 2025 Volume & High Accuracy Investment Entry Signals - baoquankhu1.vn
Should I hold or sell Processa Pharmaceuticals Inc. nowQuarterly Portfolio Report & Accurate Entry/Exit Alerts - mfd.ru
Does Processa Pharmaceuticals Inc. have a sustainable dividendQuarterly Earnings Report & Long-Term Safe Investment Plans - mfd.ru
Is Processa Pharmaceuticals Inc likely to announce a buybackGlobal Markets & Advanced Technical Analysis Signals - baoquankhu1.vn
Fed Meeting: Should I hold or sell Processa Pharmaceuticals Inc nowWeekly Market Summary & Free Community Supported Trade Ideas - baoquankhu1.vn
Jobs Data: What makes MNTK stock attractive todayJuly 2025 Sector Moves & Real-Time Market Trend Scan - baoquankhu1.vn
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
Big Picture: Does Processa Pharmaceuticals Inc have a sustainable dividendInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn
Pharma Sector Update: Amneal Valuation, Processa Profile, and Balaxi Earnings - scoopsquare24.com
Big Money Moves: Can Processa Pharmaceuticals Inc maintain sales growth2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Patterns Watch: Does Processa Pharmaceuticals Inc align with a passive investing strategy - baoquankhu1.vn
프로세사 파마슈티컬스 (PCSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):